Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.05 |
mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.33 | 0.06 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |